Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Dent Child (Chic) ; 82(2): 84-90, 2015.
Article in English | MEDLINE | ID: mdl-26349795

ABSTRACT

PURPOSE: The purpose of this study was to evaluate the profile of pediatric oral lesions in northeastern Brazil. METHODS: Biopsy records of oral lesions were retrieved from patients aged zero to 18 years who were treated over 18 years in two university hospitals in northeastern Brazil. Routine pathological sections were re-examined and classified into six groups: (1) odontogenic and nonodontogenic cysts; (2) odontogenic tumors; (3) salivary gland pathology; (4) nonodontogenic tumors and tumor-like lesions; (5) bone pathology; and (6) miscellaneous. RESULTS: From a total of 4,690 oral biopsies, 564 (12 percent) were from children and adolescents. The largest number of cases was salivary gland pathology, followed by nonodontogenic tumors and tumor-like lesions. The most common oral biopsies were mucocele, pericoronal dental follicle, pyogenic granuloma, dentigerous cyst, and odontoma. Only three cases of malignant tumors were observed. Our results were similar to most studies. CONCLUSIONS: Although malignant tumors comprised a small portion of the pediatric oral biopsies, the possibility of their occurrence in children and adolescents should not be overlooked.


Subject(s)
Stomatognathic Diseases/epidemiology , Adolescent , Biopsy , Brazil/epidemiology , Child , Child, Preschool , Female , Hospitals, University , Humans , Infant , Infant, Newborn , Male , Retrospective Studies , Stomatognathic Diseases/pathology
3.
J Craniofac Surg ; 24(4): e401-3, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23851735

ABSTRACT

Pemetrexed is a novel, multitargeted antifolate approved for the treatment of malignant pleural mesothelioma and non-small cell lung cancer. Although pemetrexed is a safe drug, some adverse effects such as myelosupression and cutaneous reactions are observed. Pemetrexed-induced eyelid edema is a rare side effect of pemetrexed treatment, and until this moment few cases were reported in the medical literature. We reported a new case of pemetrexed-induced eyelid edema in a patient with adenocarcinoma of the lung with brain metastases.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/adverse effects , Brain Neoplasms/drug therapy , Edema/chemically induced , Eyelid Diseases/chemically induced , Glutamates/adverse effects , Guanine/analogs & derivatives , Adenocarcinoma/radiotherapy , Adenocarcinoma/secondary , Antineoplastic Agents/therapeutic use , Brain Neoplasms/radiotherapy , Brain Neoplasms/secondary , Carboplatin/therapeutic use , Dexamethasone/therapeutic use , Diuretics/therapeutic use , Edema/drug therapy , Eyelid Diseases/drug therapy , Female , Folic Acid/therapeutic use , Furosemide/therapeutic use , Glucocorticoids/therapeutic use , Guanine/adverse effects , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Middle Aged , Pemetrexed , Vitamin B 12/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...